In the latest trading session, 2.28 million Petros Pharmaceuticals Inc (NASDAQ:PTPI) shares changed hands as the company’s beta touched 2.00. With the company’s most recent per share price at $0.08 changing hands around $0.0 or -4.74% at last look, the market valuation stands at $2.41M. PTPI’s current price is a discount, trading about -1987.5% off its 52-week high of $1.67. The share price had its 52-week low at $0.07, which suggests the last value was 12.5% up since then. When we look at Petros Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 11.72 million shares, with the 3-month average coming to 7.76 million.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Instantly PTPI was in red as seen in intraday trades today. With action -14.74%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -79.59%, with the 5-day performance at -14.74% in the red. However, in the 30-day time frame, Petros Pharmaceuticals Inc (NASDAQ:PTPI) is -67.52% down. Looking at the short shares, we see there were 0.35 million shares sold at short interest cover period of 0.03 days.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 6.81% of Petros Pharmaceuticals Inc shares while 10.28% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 11.04%.

Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 35.02 shares estimated at $2784.0 under it, the former controlled 0.12% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.11% of the shares, roughly 31.81 shares worth around $2528.0.